Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest

Trump administration announced tariffs on imported pharmaceuticals, including 100% tariffs on patented drugs and APIs.

Generics and UK imports are exempt; Japan and the EU face 15%, while some firms face 20% or MFN exemptions.

ForSight Robotics completed 12 robotic-assisted cataract surgeries in the Philippines and plans more trials toward FDA approval.

Medvi received an FDA warning over compounded GLP-1 marketing, and Neurocrine agreed to buy Soleno for $2.9 billion.